Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to acquire the exclusive rights for advanced cannabis products.
基于大麻素的药品公司MediPharm Labs Corp.(tsx: LABS)(OTCQB:MEDIF)(FSE: MLZ)周四宣布已与Remidose Aerosols Inc.达成许可协议,以获得先进大麻产品的独家权利。
Under the deal, current Remidose customers will be serviced through MediPharm starting August 2024, including Canadian direct-to-patient medical platforms and international medical distributors.
根据协议,包括加拿大患者平台和国际医疗分销商在内的当前Remidose客户将从2024年8月开始通过MediPharm进行服务。
MediPharm intends to utilize its existing GMP infrastructure, customer channels and wellness sales expertise to expand the customer base of these advanced products in Canada and internationally.
MediPharm打算利用其现有的GMP基础架构、客户渠道和健康销售专业知识来拓展这些先进产品在加拿大和国际市场的客户群。
See also: Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'
参见:大麻素药品公司MediPharm的营收增长,CFO称公司财务状况强劲。
Learn more about innovation in cannabis at the upcoming Benzinga cannabis event. The 19th Benzinga Cannabis Capital Conference, returns to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.
了解更多大麻创新,请参加即将到来的Benzinga大麻事件。第19届Benzinga大麻资本会议将于10月8日至9日回归芝加哥。立即通过此链接购买票。
The products in question are split into two main categories, including:
涉及的产品分为两大类,包括:
- Metered Dose Inhalers. Why? Used in the pharmaceutical industry as well, this inhalation format provides rapid onset without the adverse effects of smoking.
- Pressurized Sublingual Sprays. Why? Providing users with an accurate and repeatable experience, this aerosol delivery method has a faster onset, better bioavailability and a more pleasant taste and feel.
- 计量剂量吸入器。为什么?在制药行业中也用于此,该吸入方式提供快速的起效作用,而不会产生吸烟的不良影响。
- 加压舌下喷雾剂。为什么?提供用户准确可重复的体验,这种气溶胶传递方式具有更快的起效作用,更好的生物利用度和更美妙的口感和体验。
"MediPharm Labs is committed to providing access to non-smokeable, precision-dosed formats for cannabis patients and wellness consumers," David Pidduck, CEO of MediPharm said. "This agreement, in addition to bringing immediate revenue, opens many new potential global medical opportunities."
“MediPharm Labs致力于为大麻患者和健康消费者提供非可吸烟,精密剂量格式,” MediPharm首席执行官David Pidduck说。“除了可带来即时收入外,此次协议还为全球许多新的潜在医疗机会打开了大门。”
MediPharm already has the requisite equipment and GMP facility for these product lines to be manufactured in-house with no material incremental capital costs.
MediPharm已经具备必备设备和GMP工厂,这些产品线可以在公司内部制造,不需要额外的资本成本。
Now read: This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
现在阅读:此大麻素药品公司看到2023年营收同比增长50%,减少亏损。